We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+23.47%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$558M
AUM Growth
+$37.6M
Cap. Flow
-$24.1M
Cap. Flow %
-4.32%
Top 10 Hldgs %
33.83%
Holding
112
New
24
Increased
27
Reduced
29
Closed
27

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$6.49M
2
MOH icon
Molina Healthcare
MOH
+$6.13M
3
CNC icon
Centene
CNC
+$5.55M
4
DXCM icon
DexCom
DXCM
+$5.21M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 36.91%
2 Technology 14.91%
3 Communication Services 9.68%
4 Consumer Discretionary 8.3%
5 Materials 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILMN icon
51
Illumina
ILMN
$30.4B
$4.4M 0.79%
+12,336
New +$3.95M
VEEV icon
52
Veeva Systems
VEEV
$34.4B
$4.3M 0.77%
39,500
+19,500
+98% +$1.77M
ALLK
53
DELISTED
Allakos
ALLK
$4.28M 0.77%
+95,071
New +$3.9M
MLM icon
54
Martin Marietta Materials
MLM
$33.6B
$4.18M 0.75%
23,000
-2,000
-8% -$413K
MDB icon
55
MongoDB
MDB
$30.4B
$3.92M 0.7%
+48,000
New +$3.2M
SGI
56
Somnigroup International
SGI
$14.8B
$3.81M 0.68%
+288,000
New +$3.84M
ETSY icon
57
Etsy
ETSY
$8.13B
$3.75M 0.67%
73,000
-144,000
-66% -$6.63M
INGN icon
58
Inogen
INGN
$180M
$3.66M 0.66%
15,000
-4,500
-23% -$1.04M
W icon
59
Wayfair
W
$14.6B
$3.62M 0.65%
24,500
-14,500
-37% -$1.84M
GOOS
60
Canada Goose Holdings
GOOS
$884M
$3.61M 0.65%
+56,000
New +$3.27M
EHTH icon
61
eHealth
EHTH
$41.9M
$3.55M 0.64%
+125,633
New +$3.34M
VRTX icon
62
Vertex Pharmaceuticals
VRTX
$124B
$3.47M 0.62%
18,000
+6,000
+50% +$1.07M
NYT icon
63
New York Times
NYT
$10.5B
$3.42M 0.61%
+147,700
New +$3.54M
CF icon
64
CF Industries
CF
$18B
$3.1M 0.56%
+57,000
New +$2.75M
MDGL icon
65
Madrigal Pharmaceuticals
MDGL
$11.7B
$3M 0.54%
14,000
-12,499
-47% -$3.14M
META icon
66
Meta Platforms (Facebook)
META
$1.51T
$2.96M 0.53%
18,000
-23,000
-56% -$4.16M
LOXO
67
DELISTED
Loxo Oncology, Inc
LOXO
$2.9M 0.52%
17,000
-3,000
-15% -$504K
SFIX
68
Stitch Fix
SFIX
$572M
$2.86M 0.51%
+65,292
New +$2.38M
ICUI icon
69
ICU Medical
ICUI
$4.23B
$2.83M 0.51%
10,000
-8,500
-46% -$2.49M
LIVN icon
70
LivaNova
LIVN
$4.26B
$2.73M 0.49%
+22,000
New +$2.59M
BLUE
71
DELISTED
bluebird bio
BLUE
$2.64M 0.47%
1,397
-31
-2% -$64K
ZGNX
72
DELISTED
Zogenix, Inc.
ZGNX
$2.53M 0.45%
51,000
+1,000
+2% +$50.9K
ANET icon
73
Arista Networks
ANET
$248B
$2.53M 0.45%
152,000
-88,000
-37% -$1.5M
MNTA
74
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.5M 0.45%
95,000
+6,000
+7% +$162K
ADSK icon
75
Autodesk
ADSK
$50.7B
$2.19M 0.39%
14,000
-36,000
-72% -$5.08M

Similar funds

Atika Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Atika Capital Management held 112 positions worth $558M, up 7.2% from $520M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management withdrew a net $24.1M in Q3 2018, closing 27 positions and reducing 29 holdings. Its most notable exit was WW International, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Atika Capital Management opened a new position in Elevance Health worth $6.85M.

  • Atika Capital Management's largest Q3 2018 buy was Elevance Health: 25,000 shares worth $6.85M.
  • Atika Capital Management added most to DexCom in Q3 2018, an estimated $5.21M increase.
  • Atika Capital Management's biggest Q3 2018 reduction was Etsy, cutting an estimated $6.63M.
  • Atika Capital Management fully exited WW International in Q3 2018, selling an estimated $12.1M.
  • Atika Capital Management's ten largest holdings make up 34% of its $558M portfolio in Q3 2018.
  • Atika Capital Management opened 24 new positions and closed 27 in Q3 2018.
  • Atika Capital Management's portfolio value rose 7.2% quarter-over-quarter to $558M.

Based on Atika Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.